Do bisphosphonates and RANKL inhibitors alter the progression of coronary artery calcification? A systematic review

Do bisphosphonates and RANKL inhibitors alter the progression of coronary artery calcification? A systematic review

Objectives To determine whether bisphosphonates and NF-κB ligand (RANKL) inhibitors delay coronary artery calcification (CAC).Design A systematic review was conducted.Data sources MEDLINE, EMBASE and CENTRAL.Eligibility criteria Longitudinal studies investigating CAC progression in adults (>1...

Full description

Bibliographic Details
Main Authors: Kanika Chaudhri, Sonali R Gnanenthiran, Samantha Louise Saunders, Nathan Scott McOrist, Grant Shalaby, Karen Gladysz
Format: Article
Language:English
Published: BMJ Publishing Group 2024-09-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/14/9/e084516.full

Internet

https://bmjopen.bmj.com/content/14/9/e084516.full

Similar Items